The NNSA intends to grant SHINE Technologies cost-share funding to build and operate a new facility for producing the medical isotope molybdenum-99 (Mo-99) without the use of highly-enriched uranium, according to a March 4 filing in the Federal Register.
The agency…                    
                    
                    
                                        
                    
                
                    Nuclear Security & Deterrence Monitor Vol. 28 No. 10
Visit Archives | Return to Issue PDF
            
            
            Visit Archives | Return to Issue PDF
                Nuclear Security & Deterrence Monitor
            
            
        Article 3 of 6
             March 08, 2024
            NNSA to help fund Shine Technologies new medical isotope production facility
        Partner Content
    
    
			Jobs